Aridis Pharmaceuticals begins Aerucin Stage 1 clinical study for treatment of acute pneumonia Aridis Pharmaceuticals, Inc. Aerucin has also filed for Orphan Disease Designation with the U.S synthroid100mcg.net/hypothyroidism-in-adults.html . Drug and Meals Administration in the usa and in Europe. The clinical trial, likely to complete in the 3rd quarter of 2015, is usually a Phase 1 solitary ascending dose research in healthful volunteers. Advancing to the stage of development represents the culmination of longstanding collaborations with Harvard University and the National Institutes of Health.
At Weill Cornell, we had the opportunity to participate in the OptionELITE evaluation and found the device to be simply as safe and stable as the Option, without migrations and significantly easier to retrieve,’ said David W. Trost , MD, Associate Professor of Clinical Radiology, Weill Medical University of Cornell University in New York, NY.. Argon Medical Products releases OptionELITE Retrievable Vena Cava Filter Continuing our commitment to provide best-in-class medical devices designed for the prevention of recurrent pulmonary embolism , Argon Medical Products, Inc. The OptionELITE IVC Filtration system, created by Rex Medical, LP, provides the clinician with the same secure and trusted design now enhanced for simple delivery and retrievability. ‘Basic safety and retrievability are without query two of the most vital, and rare, characteristics in a best-in-course retrievable IVC filter.